Approxima
PrivateLast Round
Series A
Feb 20, 2025
Total Funding Raised
$1.72M
Company Overview
Approxima is a medtech company developing a minimally invasive tricuspid valve repair system based on a right ventricular reshaping approach to treat patients with tricuspid regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Approxima Comps
Public and private peers based on sector, stage, and business model.
Approxima Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 20, 2025 | ||||
| Seed | Feb 6, 2023 |
Key People
Founding team and executive leadership
Approxima Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Club degli Investitori | Seed, Series A |
| Panakès Partners | Seed, Series A |
| ENEA-Tech and Biomedical Foundation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 20, 2025
Raised $7.65M in Series A funding.
Approxima Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Approxima's valuation, stock price, and market status.
